Literature DB >> 6609121

Characterization of a human X mouse T cell hybridoma and identification of a clone secreting and binding interleukin-2.

L G Durrant, M Parkar, N Kenworthy, G M Taylor.   

Abstract

Human lymphocytes stimulated with phytohaemagglutinin (PHA) were fused with an HGPRT- murine lymphoma, BW5147, and a hybridoma BwFc93-1 was isolated and cloned in agarose. This human X mouse hybrid and nine clones derived from it were characterized by chromosome analysis, phenotypic and functional assays. Karyotyping and isoenzyme studies showed the presence of five human chromosomes in BwFc93-1 with preferential retention of three chromosomes--6, X and 15--in the clones. Membrane immunofluorescence analysis revealed that all the clones expressed human and mouse class 1 MHC antigens and the mouse T cell antigens Thy-1 and T200, but were devoid of human OKT3, OKT8 and mouse Lyt-2. Human OKT4 and OKM1 phenotypes were transiently expressed by one clone and mouse Lyt 1 by two other clones. Several T4-, Lyt-1- clones produced and bound human interleukin-2 (IL-2) indicating a lack of correlation between human T cell phenotype and function in those hybrids. There was also evidence of dichotomy in the secretion of IL-2 and expression of the IL-2 receptor since clones were identified which either bound or secreted IL-2. One clone expressing IL-2 receptors could be induced to produce human IL-2 by simultaneously stimulating with PHA and phorbol myristate acetate (PMA).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609121      PMCID: PMC1454574     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

5.  Segregation of mouse hemopoietic progenitor cells using the monoclonal antibody, YBM/42.

Authors:  S M Watt; D J Gilmore; D Metcalf; S P Cobbold; T K Hoang; H Waldmann
Journal:  J Cell Physiol       Date:  1983-04       Impact factor: 6.384

6.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

7.  Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens.

Authors:  F M Brodsky; W F Bodmer; P Parham
Journal:  Eur J Immunol       Date:  1979-07       Impact factor: 5.532

8.  Mouse/human T-cell hybrids rosetting with sheep erythrocytes.

Authors:  H A Suomalainen; R A Goldsby; B A Osborne; J Schröder
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  Antigen-specific human T-cell hybridomas with helper activity.

Authors:  E C DeFreitas; S Vella; A Linnenbach; C Zmijewski; H Koprowski; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

10.  Human serum albumin phenotype activation in mouse hepatoma--human leukocyte cell hybrids.

Authors:  G J Darlington; H P Bernard; F H Ruddle
Journal:  Science       Date:  1974-09-06       Impact factor: 47.728

View more
  3 in total

1.  Expression of human CD antigens, including CD1 and CD25, by human x mouse interlineage leukaemia hybrids.

Authors:  G M Taylor; H Morten; T Carr; C Harrison; J Ridway; P Morris Jones
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

2.  Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.

Authors:  L G Durrant; M C Garnett; J Gallego; N C Armitage; K C Ballantyne; R A Marksman; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

3.  Antigenicity of newly established colorectal carcinoma cell lines.

Authors:  L G Durrant; R A Robins; M V Pimm; A C Perkins; N C Armitage; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.